[Letter: Tardive dyskinesia, a little-known extrapyramidal syndrome due to therapy with neuroleptics].
D000367:Age Factors; D014150:Antipsychotic Agents / Q000009:adverse effects; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D002090:Butyrophenones / Q000009:adverse effects; D005260:Female; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D012737:Sex Factors; D013577:Syndrome; D013892:Thioxanthenes / Q000009:adverse effects; D013981:Tic Disorders / Q000139:chemically induced; D014149:Tranquilizing Agents / Q000009:adverse effects*; D014268:Trifluoperazine / Q000009:adverse effects
D014150:Antipsychotic Agents; D002090:Butyrophenones; D006634:Histamine H1 Antagonists; D013892:Thioxanthenes; D014149:Tranquilizing Agents; D014268:Trifluoperazine
Tarfive Dyskinesie, ein wenig bekanntes extrapyramidales Syndrom als Folge der Therapie mit Neuroleptika.